Daiichi Sankyo Official Seeks VC, Biotech Ties For More M&As
This article was originally published in PharmAsia News
Executive Summary
Daiichi Sankyo plans to build on its acquisition of Germany's U3 Pharma biotech two years ago by seeking more acquisitions or partnerships to develop cancer treatments